Lineage Cell Therapeutics logo
Lineage Cell Therapeutics LCTX
$ 0.55 9.22%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Lineage Cell Therapeutics General and Administrative Expenses 2011-2024 | LCTX

Annual General and Administrative Expenses Lineage Cell Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
17.3 M 22.5 M 18.2 M 15.6 M 24 M 24.7 M 19.9 M 28.4 M 29.1 M 17.6 M 15.6 M 10.4 M -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
29.1 M 10.4 M 20.3 M

Quarterly General and Administrative Expenses Lineage Cell Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
4.41 M 4.36 M 5 M - 4.04 M 4.25 M 4.72 M - 4.42 M 5.27 M 8.47 M - 5.32 M 4.54 M 3.94 M - 3.63 M 3.91 M 4.52 M - 4.61 M 6.26 M 8.66 M - 6.42 M 5.23 M 6.04 M - 4.59 M 4.42 M 5.1 M - 4.57 M 6.64 M 11.9 M - 7.54 M 6.19 M 5.18 M - 4.26 M 4.84 M 3.67 M - 4.27 M 3.62 M 3.42 M - 2.23 M 2.41 M 2.37 M - 1.89 M 2.4 M 1.9 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
11.9 M 1.89 M 4.8 M